Clinical outcomes of older patients with NPM1 -mutated or KMT2A- rearranged AML before menin inhibitors: a Beat AML report

Blood Advances 2026 Open access

Read full text
Authors: Joshua F. Zeidner, Jayanshu Jain, Rina Li Welkie, Ying Huang, Swords Rl, E. Traer, Eytan M. Stein, Tara L. Lin, Yazan F. Madanat, Robert H. Collins, Maria R Baer, Vu Huy Hoang Duong
+23 more William Blum, M. L. Arellano, Wendy A Stock, Olatoyosi Odenike, Rebecca Leah Olin, Catherine Choy Smith, James M. Foran, Gary John Schiller, Emily K. Curran, Shivani Handa, Nyla A. Heerema, Timothy L Chen, Molly Martycz, Mona Stefanos, Sonja Gullen Marcus, Leonard Rosenberg, Brian J. Druker, Ross L Levine, Amy L. Burd, Ashley Owen Yocum, Alice S. Mims, J. Byrd, Uma Borate
DOI: 10.1182/bloodadvances.2025019153
Cited by: 1
References: 17

Fields of Study & Subjects

Acute Myeloid Leukemia Research Amyotrophic Lateral Sclerosis Research Protein Degradation and Inhibitors

Publication details

Journal / source
Blood Advances
Publisher
American Society of Hematology
Volume
10
Issue
7
Pages
2328–2332
Publication date
3 February 2026
Language
EN